HOME >> MEDICINE >> NEWS
Study evaluates benefits and risks of tamoxifen and raloxifene for reducing risk of breast cancer

Raloxifene and tamoxifen are both effective in reducing the risk of invasive breast cancer, but each has potential disease and quality of life side effects that women and their physicians will need to consider, according to two reports and an editorial published online June 5 by JAMA. The papers are being published online to coincide with the scientific presentation of this information at the annual American Society of Clinical Oncology meeting in Atlanta. The papers will be published in the June 21 issue of JAMA.

Tamoxifen is a selective estrogen receptor modulator (SERM) that has been used to treat both early and advanced breast cancer for more than three decades, according to background information in the article. Raloxifene is a second-generation SERM currently used as a medication for the prevention and treatment of osteoporosis. But clinical trials have shown it may have a role in reducing the risk of invasive breast cancer in postmenopausal women.

Victor G. Vogel, M.D., M.H.S., from Magee-Womens Hospital, University of Pittsburgh School of Medicine, and colleagues from The National Surgical Adjuvant Breast and Bowel Project (NSABP), conducted a randomized clinical trial (Study of Tamoxifen and Raloxifene or STAR trial) at nearly 200 clinical centers throughout North America. Patients were 19,747 postmenopausal women with an average age of 58.5 years with an increased five-year breast cancer risk. The study patients were randomized to receive oral tamoxifen (20 mg/day) or raloxifene (60 mg/day) over five years.

"There were 163 cases of invasive breast cancer in women assigned to tamoxifen and 168 in those assigned to raloxifene (incidence, 4.30 per 1,000 vs. 4.41 per 1,000)," according to the study authors. There were fewer cases of noninvasive breast cancer in the tamoxifen group (57 cases) than in the raloxifene group (80 cases), while there were 36 cases of uterine cancer with tamoxifen and 23 with raloxifene; however, neit
'"/>

Contact: Clare Collins
412-352-2886
JAMA and Archives Journals
5-Jun-2006


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ROCK, Ark. (PRWEB) , ... February 19, 2019 ... ... acquisition of the Case Management Administrator Certification (CMAC). Originally developed and launched by ... is to measure the competence of case management administrators, managers, supervisors and leaders. ...
(Date:2/19/2019)... ... February 19, 2019 , ... Renowned eye ... has launched the first ever supplement to help support Keratoconus cornea health. ... vision loss. The supplement, KC Defense, includes specific amounts Copper (Cu) and Selenium ...
(Date:2/19/2019)... ... 19, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... statutory advisor to the U.S. Department of Health and Human Services (HHS), today issued ... was issued following the release last week at the HIMSS Global Conference and Exhibition ...
(Date:2/19/2019)... ... 19, 2019 , ... In one of the first research ... a team led by a Worcester Polytechnic Institute professor found that women who ... greater weight gain during pregnancy, and weight retention after their baby is born. ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Alejandro Kovacs of ... or without a referral who are interested in full arch permanent replacement solutions ... places All-on-4® dental implants in Texarkana, TX, for those completely missing ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... ... treatment for gum disease that utilizes modern dental lasers. The Laser Assisted New ... remove bacteria and diseased tissue, the leading cause of gum disease. Dr. Farahmand ...
(Date:2/19/2019)... , ... February 19, 2019 , ... Dr. Jacqueline Subka, ... in Calabasas, California, to make an appointment at her Simi Valley office to ... tooth replacement, as they can last 20 years or longer with proper care and ...
(Date:2/19/2019)... ... February 19, 2019 , ... American Friends of Sheba Medical Center, Tel ... awareness and support for Israel’s national hospital, Sheba Medical Center, Tel HaShomer. Established in ... is the largest and most comprehensive medical center in the entire Middle East. ...
Breaking Medicine Technology:
Cached News: